Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of GBP 108.93 billion. The enterprise value is 117.98 billion.
Market Cap | 108.93B |
Enterprise Value | 117.98B |
Important Dates
The last earnings date was Thursday, January 30, 2025.
Earnings Date | Jan 30, 2025 |
Ex-Dividend Date | May 9, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.40% |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 22.93.
PE Ratio | 22.93 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 11.52 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 24.84 |
EV / Sales | 3.19 |
EV / EBITDA | 11.34 |
EV / EBIT | 15.46 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.23.
Current Ratio | 1.46 |
Quick Ratio | 0.28 |
Debt / Equity | 0.23 |
Debt / EBITDA | 1.45 |
Debt / FCF | n/a |
Interest Coverage | 8.45 |
Financial Efficiency
Return on equity (ROE) is 7.53% and return on invested capital (ROIC) is 6.01%.
Return on Equity (ROE) | 7.53% |
Return on Assets (ROA) | 4.37% |
Return on Invested Capital (ROIC) | 6.01% |
Return on Capital Employed (ROCE) | 8.73% |
Revenue Per Employee | 425,416 |
Profits Per Employee | 55,177 |
Employee Count | 86,088 |
Asset Turnover | 0.34 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.38% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +7.38% |
50-Day Moving Average | 49.15 |
200-Day Moving Average | 51.29 |
Relative Strength Index (RSI) | 69.38 |
Average Volume (20 Days) | 9,837 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of GBP 36.62 billion and earned 4.75 billion in profits. Earnings per share was 3.80.
Revenue | 36.62B |
Gross Profit | 25.70B |
Operating Income | 7.50B |
Pretax Income | 5.79B |
Net Income | 4.75B |
EBITDA | 10.24B |
EBIT | 7.50B |
Earnings Per Share (EPS) | 3.80 |
Balance Sheet
The company has 6.15 billion in cash and 14.81 billion in debt, giving a net cash position of -8.65 billion.
Cash & Cash Equivalents | 6.15B |
Total Debt | 14.81B |
Net Cash | -8.65B |
Net Cash Per Share | n/a |
Equity (Book Value) | 64.54B |
Book Value Per Share | 51.25 |
Working Capital | 11.10B |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 70.18%, with operating and profit margins of 20.48% and 12.97%.
Gross Margin | 70.18% |
Operating Margin | 20.48% |
Pretax Margin | 15.80% |
Profit Margin | 12.97% |
EBITDA Margin | 27.97% |
EBIT Margin | 20.48% |
FCF Margin | n/a |
Dividends & Yields
Sanofi does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | 6.57% |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | 0.40% |
Shareholder Yield | 0.40% |
Earnings Yield | 4.36% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |